Skip to main content

Table 1 Baseline characteristics of patients with hepatocellular carcinoma

From: Value of T1 mapping on gadoxetic acid-enhanced MRI for microvascular invasion of hepatocellular carcinoma: a retrospective study

Characteristics

All patients (n = 94)

MVI

P value

Negative (n = 56)

Positive (n = 38)

Gender

   

0.217

 Male

88 (93.6%)

54 (57.4%)

34 (36.2%)

 

 Female

6 (6.4%)

2 (2.1%)

4 (4.3%)

 

Age, years (range)

52 ± 11 (24–75)

52 ± 10 (30–73)

53 ± 12 (24–75)

0.744

Diameter, cm (range)

1.9 ± 0.8 (1.2–4.5)

1.8 ± 0.8 (1.2–3.5)

2.2 ± 0.7 (1.4–4.5)

0.078

Etiology

   

0.190

 HBV

87 (92.6%)

54 (57.4%)

33 (35.1%)

 

 HCV

5 (5.3%)

1 (1.1%)

4 (4.2%)

 

 Alcohol or none

2 (2.1%)

1 (1.1%)

1 (1.1%)

 

Presence of cirrhosis

   

0.754

 Presence

66 (70.2%)

40 (42.6%)

26 (27.7%)

 

 Absence

28 (29.8%)

16 (17.0%)

12 (12.7%)

 

Edmondson-Steiner grade

   

0.380

 I-II

57 (60.6%)

36 (38.3%)

21 (22.3%)

 

 III-IV

37 (39.4%)

20 (21.3%)

17 (18.1%)

 

AFP > 20 ng/ml

   

> 0.99

 Positive

51 (54.3%)

30 (31.9%)

21 (22.3%)

 

 Negative

43 (45.7%)

26 (27.7%)

17 (18.1%)

 

Child-Pugh

   

> 0.99

 A

91 (96.8%)

54 (57.4%)

37 (39.4%)

 

 B

3 (3.2%)

2 (2.1%)

1 (1.1%)

 
  1. HBV Hepatitis B virus, HCV Hepatitis C virus, AFP a-fetoprotein, MVI Microvascular invasion